method for determination of drug tolerance at the first stage of clinical examination and research of bioequivalency

• 1. 一种用于生物等效性研究的他达拉非口喷剂自动给药装置 [P] . 中国专利： CN213724351U . 2021-07-20
• 2. 用于吸入制剂药代动力学及生物等效性研究的负压给药室 [P] . 中国专利： CN214232337U . 2021-09-21
• 3. CLINICAL EXAMINATION ITEM DETERMINATION DEVICE, HEALTHY BEHAVIOR ASSISTING DEVICE, CLINICAL EXAMINATION ITEM DETERMINATION METHOD, HEALTHY BEHAVIOR ASSISTING METHOD, AND COMPUTER PROGRAM [P] . WO2021199324A1 . 2021-10-07

  机译： 临床检查项目确定装置，健康行为辅助装置，临床检查项目确定方法，健康行为辅助方法和计算机程序

• 4. CLINICAL EXAMINATION SYSTEM AND DETERMINATION SUPPORT METHOD OF EXAMINATION ITEM IN CLINICAL EXAMINATION SYSTEM [P] . 日本专利： JP2003281273A . 2003-10-03

  机译： 临床检查系统和临床检查系统中检查项目的确定支持方法

• 5. method for determination of tolerance to drugs during the first phase of clinical researches [P] . UA94156C2 . 2011-04-11

  机译： 临床研究第一阶段的药物耐受性测定方法

• 1. Screening Methods for Waterlogging Tolerance at Maize (Zea mays L.)Seedling Stage [J] . LIU Yong-zhong, TANG Bin, ZHENG Yong-lian, 农业科学学报（英文版） . 2010,第003期
• 2. Determination of lercanidipine in human plasma by an improved UPLC-MS/MS method for a bioequivalence study$ [J] . Darshan V. Chaudhary, Daxesh P. Patel, Priyanka A. Shah, 药物分析学报（英文） . 2016,第002期
• 3. Liquid chromatography-tandem mass spectrometry method for simultaneous determination of albendazole and albendazole sulfoxide in human plasma for bioequivalence studies$ [J] . Dhiraj M. Rathod, Keyur R. Patel, Hiren N. Mistri, 药物分析学报（英文） . 2016,第004期
• 4. A systematic study of the effect of low pH acid treatment on anti-drug antibodies specific for a domain antibody therapeutic: Impact on drug tolerance, assay sensitivity and post-validation method assessment of ADA in clinical serum samples [J] . Kavita Uma, Duo Jia, Crawford Sean M., Journal of Immunological Methods . 2017,第期
• 5. Practical method for determination of air kerma by use of an ionization chamber toward construction of a secondary X-ray field to be used in clinical examination rooms [J] . Radiological physics and technology . 2016,第2期
• 6. Review of the validated HPLC and LC-MS/MS methods for determination of drugs used in clinical practice for Alzheimer's disease [J] . Sulochana Suresh Ponnayyan, Sharma Kuldeep, Mullangi Ramesh, Biomedical Chromatography: An International Journal Devoted to Research in Chromatographic Methodologies and Their Applications in the Biosciences . 2014,第11期
• 7. Comparison of Three Methods for Power and Sample Size Determination in Bioequivalence Test [C] . WANG Jiu, YU Lili 2009 International Institute of Applied Statistics Studies(2009 国际应用统计学术研讨会）论文集 . 2009
• 8. Constrained Maximum Entropy Models for Selecting Genotype Interactions Associated with Interval-Censored Failure Times and Methods for Power Calculation in a Three-Arm Four-Step Clinical Bioequivalence Study [D] . Yang, Aotian. 2018
• 9. Development of a Robust UPLC Method for Simultaneous Determination of a Novel Combination of Sofosbuvir and Daclatasvir in Human Plasma: Clinical Application to Therapeutic Drug Monitoring [O] . Naser F. Al-Tannak, Ahmed Hemdan, Maya S. Eissa 2018
• 10. Development of a Robust UPLC Method for Simultaneous Determination of a Novel Combination of Sofosbuvir and Daclatasvir in Human Plasma: Clinical Application to Therapeutic Drug Monitoring [O] . Naser F. Al-Tannak, Ahmed Hemdan, Maya S. Eissa 2018

• 1. LC-MS/MS Method for Determination of Megestrol in Human Plasma and Its Application in Bioequivalence Study [J] . Fan LI ,Xiao-juan ZOU ,Heng ZHENG . 华中科技大学学报（医学）（英德文版） . 2013,第006期
• 2. Validated LC-MS/MS Method for the Determination of Rosuvastatin in Human Plasma: Application to a Bioequivalence Study in Chinese Volunteers [J] . Dujuan Zhang ,Jing Zhang ,Xiaoyan Liu . 药理与制药（英文） . 2011,第4期
• 3. 结核分枝杆菌临床株的乙胺丁醇耐药性与异烟肼和利福平耐药性的关系研究 [C] . 程君 ,凌颖 ,李志玲 . 中华医学会结核病学分会2012年学术大会 . 2012
• 4. 血浆尿嘧啶核苷测定方法的建立及胞磷胆碱钠片生物等效性研究 [A] . 曹明亮 . 2011